4
Changes in Ownership
Starling Oncology, Inc. Filed Acc 0001104659-21-140220
Director acquired 30,000 shares (conversion)
- Director returned 4,466 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Kaushal Mohit · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-12 | Conversion : show line 1 in the form | +30,000 | 30,000 | D |
| 2021-11-12 | Returned to the company : show line 2 in the form | −4,466 | 25,534 | D |
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-11-12 | Conversion : show line 3 in the form Class B Common Stock | −30,000 | 0 | D |
Loading xslF345X03/tm2132979-14_4seq1.xml…